Radiation
Radiation is a radiation therapy with 284 clinical trials. Currently 60 active trials ongoing. Historical success rate of 73.0%.
Success Metrics
Based on 116 completed trials
Phase Distribution
Phase Distribution
72
Early Stage
131
Mid Stage
34
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
67.1%
116 of 173 finished
32.9%
57 ended early
60
trials recruiting
284
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
Clinical Trials (284)
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
Vaccination With Flt3L, Radiation, and Poly-ICLC
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy
Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.
Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 284